Assessment of cortisol response with low-dose and high-dose ACTH in patients with chronic fatigue syndrome and healthy comparison subjects

Psychosomatics

Volumn 44, Issue 2, 2003, Pages 113-119

  Gaab, Jens ^a,b   Huster D ^a   Peisen, R ^a   Engert, V ^a   Heitz, V ^a   Schad, T ^a   Schurmeyer Th ^a   Ehlert, U ^a  

^a UNIVERSITY OF TRIER   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE; TETRACOSACTIDE;

ADRENAL INSUFFICIENCY; AREA UNDER THE CURVE; ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOTROPIN TEST; DRUG MEGADOSE; DRUG RESPONSE; FEMALE; HORMONE RESPONSE; HUMAN; HYDROCORTISONE BLOOD LEVEL; LOW DRUG DOSE; MALE; RANDOMIZED CONTROLLED TRIAL; SALIVA LEVEL;

EID: 0037372213     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.44.2.113     Document Type: Article

References (34)

1. Wessely S, Chalder T, Hirsch S, Wallace P, Wright D: Psychological symptoms, somatic symptoms, and psychiatric disorder in chronic fatigue and chronic fatigue syndrome: a prospective study in the primary care setting. Am J Psychiatry 1996; 153:1050-1059
2. Poteliakhoff A: Adrenocortical activity and some clinical findings in acute and chronic fatigue. J Psychosom Res 1981; 25:91-95
3. Demitrack MA, Dale JK, Straus SE, Laue L, Listwak SJ, Kruesi MJ, Chrousos GP, Gold PW: Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 1991; 73:1224-1234
4. Gaab J, Hüster D, Peisen R, Engert V, Heitz V, Schad T, Schürmeyer T, Ehlert U: Hypothalamus-pituitary-adrenal axis reactivity in chronic fatigue syndrome and health under psychological, physiological and pharmacological stimulation. Psychosom Med 2002; 64:951-962
5. Scott LV, Medbak S, Dinan TG: The low dose ACTH test in chronic fatigue syndrome and in health. Clin Endocrinol (Oxf) 1998; 48:733-737
6. Scott LV, Teh J, Reznek R, Martin A, Sohaib A, Dinan TG: Small adrenal glands in chronic fatigue syndrome: a preliminary computer tomography study. Psychoneuroendocrinology 1999; 24: 759-768
7. Hudson M, Cleare AJ: The 1 microg short Synacthen test in chronic fatigue syndrome. Clin Endocrinol (Oxf) 1999; 51:625-630
8. Dickstein G, Shechner C, Nicholson WE, Rosner I, Shen-Orr Z, Adawi F, Lahav M: Adrenocorticotropin stimulation test: effects of basal cortisol level, time of day, and suggested new sensitive low dose test. J Clin Endocrinol Metab 1991; 72:773-778
9. Reschini E, Catania A, Giustina G: Plasma cortisol response to ACTH does not accurately indicate the state of hypothalamic-pituitary-adrenal axis. J Endocrinol Invest 1982; 5:259-261
10. Crowley S, Hindmarsh PC, Holownia P, Honour JW, Brook CG: The use of low doses of ACTH in the investigation of adrenal function in man. J Endocrinol 1991; 130:475-479
11. Crowley S, Hindmarsh PC, Honour JW, Brook CG: Reproducibility of the cortisol response to stimulation with a low dose of ACTH(1-24): the effect of basal cortisol levels and comparison of low-dose with high-dose secretory dynamics. J Endocrinol 1993; 136:167-172
12. Dickstein G, Spigel D, Arad E, Shechner C: One microgram is the lowest ACTH dose to cause a maximal cortisol response. There is no diurnal variation of cortisol response to submaximal ACTH stimulation. Eur J Endocrinol 1997; 137:172-175
13. Daidoh H, Morita H, Mune T, Murayama M, Hanafusa J, Ni H, Shibata H, Yasuda K: Responses of plasma adrenocortical steroids to low dose ACTH in normal subjects. Clin Endocrinol (Oxf) 1995; 43:311-315
14. Rasmuson S, Olsson T, Hagg E: A low dose ACTH test to assess the function of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol (Oxf) 1996; 44:151-156
15. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A (International Chronic Fatigue Syndrome Study Group): The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994; 121:953-959
16. Sharpe MC, Archard LC, Banatvala JE, Borysiewicz LK, Clare AW, David A, Edwards RH, Hawton KE, Lambert HP, Lane RJ, et al: A report - chronic fatigue syndrome: guidelines for research. J R Soc Med 1991; 84:118-121
17. Wittchen H-U, Pfister H: DIA-X-Interviews. Frankfurt, Germany, Swets & Zeitlinger, 1997
18. Smets EM, Garssen B, Bonke B, De Haes JC: The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995; 39:315-325
19. Herrmann C, Buss U, Snaith RP: HADS-D Hospital Anxiety and Depression Scale - Ein Fragebogen zur Erfassung von Angst und Depressivität in der somatischen Medizin. Bern, Switzerland, Hans Huber, 1995
20. Dressendorfer RA, Kirschbaum C, Rohde W, Stahl F, Strasburger CJ: Synthesis of a cortisol-biotin conjugate and evaluation as a tracer in an immunoassay for salivary cortisol measurement. J Steroid Biochem Mol Biol 1992; 43:683-692
21. Buchner A, Faul F, Erdfelder E: G-Power: A Priori, Post Hoc, and Compromise Power Analyses for the Macintosh (Version 2.1.2). Trier, Germany, University of Trier, 1997
22. Gonzalbez J, Villabona C, Ramon J, Navarro MA, Gimenez O, Ricart W, Soler J: Establishment of reference values for standard dose short synacthen test (250 microgram), low dose short synacthen test (1 microgram) and insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in normal subjects. Clin Endocrinol (Oxf) 2000; 53:199-204
23. Kirschbaum C, Kudielka BM, Gaab J, Schommer NC, Hellhammer DH: Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis. Psychosom Med 1999; 61:154-162
24. Abdu TA, Elhadd TA, Neary R, Clayton RN: Comparison of the low dose short synacthen test (1 microg), the conventional dose short synacthen test (250 microg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease. J Clin Endocrinol Metab 1999; 84: 838-843
25. Parker AJ, Wessely S, Cleare AJ: The neuroendocrinology of chronic fatigue syndrome and fibromyalgia. Psychol Med 2001; 31:1331-1345
26. Cleare AJ, Miell J, Heap E, Sookdeo S, Young L, Malhi GS, O'Keane V: Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy. J Clin Endocrinol Metab 2001; 86:3545-3554
27. Chalder T, Power MJ, Wessely S: Chronic fatigue in the community: "a question of attribution." Psychol Med 1996; 26:791-800
28. Powell R, Dolan R, Wessely S: Attributions and self-esteem in depression and chronic fatigue syndromes. J Psychosom Res 1990; 34:665-673
29. Yunus MB: Gender differences in fibromyalgia and other related syndromes. J Gend Specif Med 2002; 5:42-47
30. Gaab J, Hellhammer DH, Ehlert U: The predominance of women in chronic fatigue syndrome: are endocrine dysregulations a possible explanation? Archives of Women's Ment Health 2001; conference proceeding, 3(suppl 2)/4:55
31. Heim C, Ehlert U, Hellhammer DH: The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology 2000; 25:1-35
32. Cleare AJ, Heap E, Malhi GS, Wessely S, O'Keane V, Miell J: Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial. Lancet 1999; 353:455-458
33. Visser J, Lentjes E, Haspels I, Graffelman W, Blauw B, de Kloet R, Nagelkerken L: Increased sensitivity to glucocorticoids in peripheral blood mononuclear cells of chronic fatigue syndrome patients, without evidence for altered density or affinity of glucocorticoid receptors. J Investig Med 2001; 49:195-204
34. Gaab J, Huster D, Peisen R, Engert V, Schad T, Schurmeyer TH, Ehlert U: Low-dose dexamethasone suppression test in chronic fatigue syndrome and health. Psychosom Med 2002; 64:311-318